Navigation Links
Glenmark's Consolidated Revenue Increases by 16.56% to Rs. 14630.06 Mn for Q2 FY 13-14
Date:10/31/2013

MUMBAI, October 31, 2013 /PRNewswire/ --

Net Profit for the second quarter was Rs 1542.97 Mn as compared to Rs. 1567.52 mn for the previous corresponding quarter

 

 Highlights: Q2-FY14 -Results

  • Generics business registered sales growth of  22.51%. to Rs. 7106.55 Mn in Q2
  • US Generics Business grew by 29.52% for the quarter
  • India formulations business recorded a growth 21.41% for the Quarter

     (Logo: http://photos.prnewswire.com/prnh/20130626/625083)

Glenmark Pharmaceuticals Limited (GPL), the research-led global integrated pharmaceutical company announced its results for the second quarter ended September 30, 2013

For the second quarter ended Sep 30, 2013, Glenmark's consolidated revenue was at Rs. 14630.06 Mn (USD 235.62 Mn ) as against Rs. 12551.91Mn (USD 227.89 Mn) an increase of 16.56 % .

Revenue from the generics business was at Rs.7106.55Mn (USD 114.20Mn) as against Rs. 5800.78 Mn (USD 105.27 Mn), growth of 22.51 %.  The Specialty formulation business excluding out-licensing revenue was atRs.7405.41Mn (USD 119.42Mn) as against Rs. 6751.13 Mn (USD 122.62 Mn) for the corresponding previous quarter, recording a growth of 9.69%.

Net Profit (after taxes and minority interests) for the second quarter was Rs 1542.97 Mn as compared to Rs. 1567.52 Mn for the previous corresponding quarter

 "Despite challenges in the operating environment, we have managed to register decent sales growth of 17% on the back of good performances by our USand Indiabusinesses. We have been also making steady progress on the Innovation R&D front with our 4 NCE & NBE molecules in clinical trials"; said Glenn Saldanha, Chairman &a
'/>"/>

SOURCE Glenmark Pharmaceuticals Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million
2. Neogen reports 18% revenue increase
3. Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL
4. BioLife Solutions Announces Record Revenue of $2.3 Million in the Second Quarter of 2013
5. Sales Momentum Helps Companies Drive Revenue by Getting Major Account Sales Strategy Right
6. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
7. SPO Returns to Revenue Generation
8. Global Nano-Materials Market 2002-2016: Nano-Materials Industry, Production Volumes, Revenues and End User Market Demand - MarketResearchReports.Biz
9. Medical Marijuana Inc., Corporate Update- Significant Revenue and Net Income Growth 1st Quarter- Division and Corporate Holdings Update
10. Adeptia Announces 75% Revenue Increase for 2012 Calendar Year
11. Ekahau Achieves 45% Year-over-Year Revenue Growth and Strong Adoption of Safety Alert Solution in 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... , Aug. 26, 2015 Intrexon Corporation ... announced today the closing of its previously announced public ... by the underwriters of their option to purchase an ... offering price of $41.00 per share.  The exercise of ... of common stock sold by Intrexon to 5,609,756 shares ...
(Date:8/26/2015)... HONG KONG , Aug. 26, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... Holdings Limited ("MO2"), an entity wholly owned by Mr. ... the Company, has acquired the outstanding shares (the "Shares") ...
(Date:8/26/2015)... , August 26, 2015 ... factors fueling the optimism in biotech,s forecast is ... and life sciences advancements.  Active biotechnology & healthcare ... BioSciences, Inc. (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: ... ), Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) ...
(Date:8/26/2015)... MA (PRWEB) , ... August 26, 2015 , ... The ... for Boston adult stem cell technology start-up company Asymmetrex to share the ... the capabilities of a new biomarker for counting adult tissue stem cells. , With ...
Breaking Biology Technology:Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 4
... , AMES, Iowa, July 20 ... in a Series D financing to accelerate the clinical development of ... prior investors. , , "NewLink has ... field of cancer immunotherapy," said Dr. Charles Link, Chairman and Chief ...
... , , INDIANAPOLIS and ST. ... closer to realizing the greater whole farm corn yield advantages of ... comprehensive insect and weed control and allow farmers to significantly reduce ... which is the outcome of a cross licensing agreement and research ...
... , , NEWPORT, R.I., ... improving patient-driven self-care, announced today that it will partner ... to the healthcare industry, to develop an innovative new ... and information they need to better manage their health. ...
Cached Biology Technology:Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres 2Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres 3Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres 4Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres 5Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres 6Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres 7iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers 2iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers 3
(Date:8/4/2015)... ) today reported financial and operating results for the second quarter ... quarter contract revenue of $ 85.2 million, a ... of 26 % , Second quarter adjusted ... royalties in the current quarter , Operating cash ... to present another strong financial quarter, with all our divisions achieving ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
(Date:7/31/2015)... Conn. , Jul. 31, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies such ... by introducing a common, uniform way to manage all ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... Few events involving animals are more dramatic than when ... cross-country. Among examples are the many thousands of wildebeests ... across the African plains. , Countless millions of ... with their own kind and form teeming, hungry islands ...
... components of our blood, are ancient proteins with well-known ... are also present in plants and bacteria, but until ... unclear. A group of researchers reveal this week that ... the fixation of nitrogen in the root nodules of ...
... Scientists at the U.S. Department of Energy's Brookhaven National ... in medical imaging to track the distribution of nutrients ... attack. The research provides new insights on a long-debated ... shows that radiotracer imaging can be a big help ...
Cached Biology News:Experiments provide proof of how traveling in groups protects insects 2Plant hemoglobins: Oxygen handlers critical for nitrogen fixation 2Poplar trees redirect resources in response to simulated attack 2Poplar trees redirect resources in response to simulated attack 3